StonvexLoading…
StonvexStonvexStonvexCore line items from ERNA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2020 2020-12-31 | Annual 2019 2019-12-31 | Annual 2018 2018-12-31 | Annual 2017 2017-12-31 |
|---|---|---|---|---|
Revenue | $5.80M | $19.81M | $23.34M | $21.27M |
Operating Income | $-7.25M | $-1.76M | $203.00K | $-1.40M |
Net Income | $-7.29M | $-2.05M | $-259.00K | $-1.08M |
EPS (Diluted) | $-0.41 | Not available | Not available | Not available |
Total Assets | $12.91M | $14.13M | $14.86M | $16.57M |
Total Liabilities | $5.25M | $9.03M | $7.95M | $11.03M |
Cash & Equivalents | $777.00K | $3.21M | $2.54M | $3.38M |
Free Cash Flow OCF − CapEx | $-8.14M | $2.62M | $717.00K | $-179.00K |
Shares Outstanding | 0 | 2.90M | 2.88M | 2.52M |